Jaime Bartushak - Aug 12, 2024 Form 4/A - Amendment Insider Report for CITIUS ONCOLOGY, INC. (CTOR)

Signature
/s/ Lorna A. Knick, by Power of Attorney
Stock symbol
CTOR
Transactions as of
Aug 12, 2024
Transactions value $
$0
Form type
4/A - Amendment
Date filed
8/30/2024, 04:05 PM
Date Of Original Report
Aug 14, 2024
Previous filing
Oct 12, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTOR Stock Option (Right to Buy) Award $0 +1.4M $0.00 1.4M Aug 12, 2024 Common Stock 1.4M $2.15 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option, originally issued by Citius Oncology Sub, Inc., vests over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services to Citius Oncology Sub, Inc. or a related entity as of each such vesting date. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024.
F2 This Form 4 has been amended to correct the amount of option shares held by the Reporting Person.